Screener
Tango Therapeutics TNGX Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Tango Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Tango Therapeutics’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221656
FAQ
- What is Tango Therapeutics's asset turnover?
- Tango Therapeutics (TNGX) reported asset turnover of 0.2× in Q1 2026.
- How has Tango Therapeutics's asset turnover changed year-over-year?
- Tango Therapeutics's asset turnover increased by 33.2% year-over-year, from 0.1× to 0.2×.
- What is the long-term trend for Tango Therapeutics's asset turnover?
- Over 4 years (2021 to 2025), Tango Therapeutics's asset turnover has grown at a 13.6% compound annual growth rate (CAGR), from 0.1× to 0.2×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Tango Therapeutics's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude